Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 3Phase EARLY_PHASE1 1

Status

Recruiting 4Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Carcinoma, Non-Small-Cell Lung 156Neoplasms 115Colorectal Neoplasms 98Breast Neoplasms 93Pancreatic Neoplasms 81Neoplasm Metastasis 81Leukemia, Myeloid, Acute 79Recurrence 76Prostatic Neoplasms 74Ovarian Neoplasms 74Melanoma 74Multiple Myeloma 66Stomach Neoplasms 59Lung Neoplasms 56Squamous Cell Carcinoma of Head and Neck 55Triple Negative Breast Neoplasms 50Glioblastoma 49Lymphoma 47Endometrial Neoplasms 43Carcinoma, Hepatocellular 42Advanced Solid Tumor 42Lymphoma, Non-Hodgkin 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Advanced Solid Tumors 37Small Cell Lung Carcinoma 35Uterine Cervical Neoplasms 34Carcinoma, Renal Cell 34Lymphoma, Large B-Cell, Diffuse 32Lymphoma, B-Cell 32Sarcoma 30

Interventions

trifluridine tipiracil drug combination 1pembrolizumab 1Trifluridine 1Standard of Care 1Injections 1HMPL-013 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × Advanced/Metastatic Solid Tumors × Clear all
NCT06922357 2026-05-28

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

Shandong Suncadia Medicine Co., Ltd.

Phase 1/2 Recruiting
120 enrolled
Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT07415863 2026-02-17

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

CSPC Megalith Biopharmaceutical Co.,Ltd.

Phase 1/2 Recruiting
820 enrolled
Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Adagene Inc

Phase 1/2 Recruiting
186 enrolled
Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT07102004 2025-08-03

Study of MHB088C for Patients With Advanced Solid Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Recruiting
515 enrolled
Other solid neoplasm

Advanced/Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡